BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 28545469)

  • 1. Age-related terminal duct lobular unit involution in benign tissues from Chinese breast cancer patients with luminal and triple-negative tumors.
    Guo C; Sung H; Zheng S; Guida J; Li E; Li J; Hu N; Deng J; Figueroa JD; Sherman ME; Gierach GL; Lu N; Yang XR
    Breast Cancer Res; 2017 May; 19(1):61. PubMed ID: 28545469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between quantitative measures of TDLU involution and breast tumor molecular subtypes among breast cancer cases in the Black Women's Health Study: a case-case analysis.
    Davis Lynn BC; Lord BD; Cora R; Pfeiffer RM; Lawrence S; Zirpoli G; Bethea TN; Palmer JR; Gierach GL
    Breast Cancer Res; 2022 Dec; 24(1):86. PubMed ID: 36471360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers.
    Yang XR; Figueroa JD; Falk RT; Zhang H; Pfeiffer RM; Hewitt SM; Lissowska J; Peplonska B; Brinton L; Garcia-Closas M; Sherman ME
    Breast Cancer Res; 2012 Apr; 14(2):R64. PubMed ID: 22513288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between terminal duct lobular unit features and mammographic density among Chinese breast cancer patients.
    Sung H; Guo C; Li E; Li J; Pfeiffer RM; Guida JL; Cora R; Hu N; Deng J; Figueroa JD; Sherman ME; Gierach GL; Lu N; Yang XR
    Int J Cancer; 2019 Jul; 145(1):70-77. PubMed ID: 30561789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease.
    Horne HN; Sherman ME; Pfeiffer RM; Figueroa JD; Khodr ZG; Falk RT; Pollak M; Patel DA; Palakal MM; Linville L; Papathomas D; Geller B; Vacek PM; Weaver DL; Chicoine R; Shepherd J; Mahmoudzadeh AP; Wang J; Fan B; Malkov S; Herschorn S; Hewitt SM; Brinton LA; Gierach GL
    Breast Cancer Res; 2016 Feb; 18(1):24. PubMed ID: 26893016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of Terminal Duct Lobular Unit Involution of the Breast with Area and Volume Mammographic Densities.
    Gierach GL; Patel DA; Pfeiffer RM; Figueroa JD; Linville L; Papathomas D; Johnson JM; Chicoine RE; Herschorn SD; Shepherd JA; Wang J; Malkov S; Vacek PM; Weaver DL; Fan B; Mahmoudzadeh AP; Palakal M; Xiang J; Oh H; Horne HN; Sprague BL; Hewitt SM; Brinton LA; Sherman ME
    Cancer Prev Res (Phila); 2016 Feb; 9(2):149-58. PubMed ID: 26645278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum insulin-like growth factor (IGF)-I and IGF binding protein-3 in relation to terminal duct lobular unit involution of the normal breast in Caucasian and African American women: The Susan G. Komen Tissue Bank.
    Oh H; Pfeiffer RM; Falk RT; Horne HN; Xiang J; Pollak M; Brinton LA; Storniolo AMV; Sherman ME; Gierach GL; Figueroa JD
    Int J Cancer; 2018 Aug; 143(3):496-507. PubMed ID: 29473153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terminal duct lobular unit involution of the normal breast: implications for breast cancer etiology.
    Figueroa JD; Pfeiffer RM; Patel DA; Linville L; Brinton LA; Gierach GL; Yang XR; Papathomas D; Visscher D; Mies C; Degnim AC; Anderson WF; Hewitt S; Khodr ZG; Clare SE; Storniolo AM; Sherman ME
    J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25274491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Genetic Ancestry With Terminal Duct Lobular Unit Involution Among Healthy Women.
    Sung H; Koka H; Marino N; Pfeiffer RM; Cora R; Figueroa JD; Sherman ME; Gierach GL; Yang XR
    J Natl Cancer Inst; 2022 Oct; 114(10):1420-1424. PubMed ID: 35333343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between breast cancer genetic susceptibility variants and terminal duct lobular unit involution of the breast.
    Bodelon C; Oh H; Chatterjee N; Garcia-Closas M; Palakal M; Sherman ME; Pfeiffer RM; Geller B; Vacek P; Weaver DL; Chicoine R; Papathomas D; Xiang J; Patel DA; Khodr ZG; Linville L; Clare SE; Visscher DW; Mies C; Hewitt SM; Brinton LA; Storniolo AMV; He C; Chanock SJ; Gierach GL; Figueroa JD
    Int J Cancer; 2017 Feb; 140(4):825-832. PubMed ID: 27859137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease: a nested case-control study.
    Figueroa JD; Pfeiffer RM; Brinton LA; Palakal MM; Degnim AC; Radisky D; Hartmann LC; Frost MH; Stallings Mann ML; Papathomas D; Gierach GL; Hewitt SM; Duggan MA; Visscher D; Sherman ME
    Breast Cancer Res Treat; 2016 Aug; 159(1):163-72. PubMed ID: 27488681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer.
    Yang XR; Figueroa JD; Hewitt SM; Falk RT; Pfeiffer RM; Lissowska J; Peplonska B; Brinton LA; Garcia-Closas M; Sherman ME
    Breast Cancer Res Treat; 2013 Feb; 137(3):837-47. PubMed ID: 23271326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep learning assessment of breast terminal duct lobular unit involution: Towards automated prediction of breast cancer risk.
    Wetstein SC; Onken AM; Luffman C; Baker GM; Pyle ME; Kensler KH; Liu Y; Bakker B; Vlutters R; van Leeuwen MB; Collins LC; Schnitt SJ; Pluim JPW; Tamimi RM; Heng YJ; Veta M
    PLoS One; 2020; 15(4):e0231653. PubMed ID: 32294107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ages at menarche- and menopause-related genetic variants in relation to terminal duct lobular unit involution in normal breast tissue.
    Oh H; Bodelon C; Palakal M; Chatterjee N; Sherman ME; Linville L; Geller BM; Vacek PM; Weaver DL; Chicoine RE; Papathomas D; Patel DA; Xiang J; Clare SE; Visscher DW; Mies C; Hewitt SM; Brinton LA; Storniolo AM; He C; Garcia-Closas M; Chanock SJ; Gierach GL; Figueroa JD
    Breast Cancer Res Treat; 2016 Jul; 158(2):341-50. PubMed ID: 27342457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.
    Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G
    Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating sex hormones and terminal duct lobular unit involution of the normal breast.
    Khodr ZG; Sherman ME; Pfeiffer RM; Gierach GL; Brinton LA; Falk RT; Patel DA; Linville LM; Papathomas D; Clare SE; Visscher DW; Mies C; Hewitt SM; Storniolo AM; Rosebrock A; Caban JJ; Figueroa JD
    Cancer Epidemiol Biomarkers Prev; 2014 Dec; 23(12):2765-73. PubMed ID: 25472681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between mammographic density and basal-like and luminal A breast cancer subtypes.
    Razzaghi H; Troester MA; Gierach GL; Olshan AF; Yankaskas BC; Millikan RC
    Breast Cancer Res; 2013; 15(5):R76. PubMed ID: 24008056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using Digital Pathology to Understand Epithelial Characteristics of Benign Breast Disease among Women Undergoing Diagnostic Image-Guided Breast Biopsy.
    Mullooly M; Puvanesarajah S; Fan S; Pfeiffer RM; Olsson LT; Hada M; Kirk EL; Vacek PM; Weaver DL; Shepherd J; Mahmoudzadeh A; Wang J; Malkov S; Johnson JM; Hewitt SM; Herschorn SD; Sherman ME; Troester MA; Gierach GL
    Cancer Prev Res (Phila); 2019 Dec; 12(12):861-870. PubMed ID: 31645342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern of recurrence of early breast cancer is different according to intrinsic subtype and proliferation index.
    Ribelles N; Perez-Villa L; Jerez JM; Pajares B; Vicioso L; Jimenez B; de Luque V; Franco L; Gallego E; Marquez A; Alvarez M; Sanchez-Muñoz A; Perez-Rivas L; Alba E
    Breast Cancer Res; 2013; 15(5):R98. PubMed ID: 24148581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards defining morphologic parameters of normal parous and nulliparous breast tissues by artificial intelligence.
    Ogony J; de Bel T; Radisky DC; Kachergus J; Thompson EA; Degnim AC; Ruddy KJ; Hilton T; Stallings-Mann M; Vachon C; Hoskin TL; Heckman MG; Vierkant RA; White LJ; Moore RM; Carter J; Jensen M; Pacheco-Spann L; Henry JE; Storniolo AM; Winham SJ; van der Laak J; Sherman ME
    Breast Cancer Res; 2022 Jul; 24(1):45. PubMed ID: 35821041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.